MedPath

DIPHARMA Arzneimittel GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

CIMA_AEMPS:8
EMA:2

Drug Approvals

Sapropterin Dipharma

Authorization Status
Authorised
Approval Date
Feb 16, 2022
EMA

Miglustat Dipharma

Authorization Status
Authorised
Approval Date
Feb 18, 2019
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.